New Brunswick Family Medicine · 200 patients
Good evening, Dr. Rivera.
1 trial fits your patients, with 0 pre-screen candidates between them. Ranked by how many of your patients could join. We pre-screened your panel against 39 open trials on Oct 11, 2026; patient records never left your practice.
No candidates in your panel· 5
Open trials where none of your patients pre-screened as a candidate or for chart review, or that haven't been pre-screened yet.
Chronic Obstructive Pulmonary Disease
Dupilumab
LPS18583 is a multinational, randomized, double-blind, placebo-controlled, parallel-group, Phase 4 study with 2 treatment groups. The purpose of this study is to assess the effect of dupilumab compared with placebo on airway inflammation, resistance, and remodeling including mucus plugging and its association with…
- Ages
- 40–85
- Sex
- All
- Enrolling
- 218
- Ends
- Dec 2028
Nasal Polyps
Dupilumab Prefilled Syringe
Hypothesis: The investigators hypothesize that in patients with CRSwNP who demonstrate sinus colonization with staphylococcus aureus, the administration of dupilumab will be associated with decreased staph colonization and an increase in microbial diversity. Primary Objective will be to demonstrate that dupilumab…
- Ages
- 18–65
- Sex
- All
- Enrolling
- 20
- Ends
- Jun 2026
Pulmonary Arterial Hypertension
REGN13335
This study is researching an experimental drug called REGN13335. The study is focused on participants with Pulmonary Arterial Hypertension (PAH). The aim of the study is to see how safe and effective REGN13335 is in participants with PAH who are taking other PAH medicines. The study is looking at several other…
- Ages
- 18+
- Sex
- All
- Enrolling
- 99
- Ends
- Feb 2028
Chronic Obstructive Pulmonary Disease
Dupilumab
This study is researching a drug called dupilumab, referred to as "study drug". The study is focused on people diagnosed with COPD to determine if the study drug, in addition to standard of care treatment for COPD, might reduce the reoccurrence of a COPD exacerbation (a "flare-up") happening within the study treatment…
- Ages
- 40+
- Sex
- All
- Enrolling
- 754
- Ends
- Jul 2028
Asthma
Dupilumab Injectable Product
Often when people with asthma get a virus caused by the common cold (rhinovirus), they also experience an increase or worsening of their asthma symptoms. The purpose of this study is to see if the study medication dupilumab helps prevent those with mild to moderate asthma from having increased asthma symptoms, after…
- Ages
- 18–40
- Sex
- All
- Enrolling
- 60
- Ends
- Jun 2026